US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Renaissance Technologies Holdings

1,844.86

-25.3440-1.36%

Number of Gainers:31

Number of Losers:63

Number of Flat:2

PE:- -

High:1,870.26

Open:1,870.26

Low:1,837.04

Close:1,870.21

Loading ...

These 20 stocks are likely to be losers no matter what the market does

Tech Stocks Are Plummeting: 2 Artificial Intelligence (AI) Stocks to Buy Now and Hold for Decades

BUZZ-Citigroup starts coverage on Moderna, notes risky path to profitability

Investors in Vodafone Group (LON:VOD) have unfortunately lost 27% over the last three years

Simply Wall St.

Hello Group: Strategic Financial Maneuvers and Growth Prospects Drive Buy Rating

BRIEF-Rockwell Automation Showcases Emulate3D Factory Test For The First Time At NVIDIA GTC 2025

Press Release: Bristol Myers Squibb to Report Results for First Quarter 2025 on April 24, 2025

Logistics Report: China Chides Walmart; Target Revamps Grocery Supply Chain

BRIEF-Bristol Myers Squibb To Report Results For First Quarter 2025 On April 24, 2025

EXCLUSIVE: Vivani Medical Announces First Implant In Early-Stage Human Study Of GLP-1 Implant For Obesity

Linde plc's (NASDAQ:LIN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Simply Wall St.

Snowflake Insiders Added US$15.0m Of Stock To Their Holdings

Simply Wall St.

Press Release: AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update

Bristol Myers Squibb to Report Results for First Quarter 2025 on April 24, 2025

THOMSON REUTERS

Trump's Chips War Has Left Intel's New CEO With a Near-Impossible Task. Here's Why and 5 Other Things to Know Today. -- Barrons.com

ForexIGO Bridges Gold and GBP/USD Trading in a Single AI Solution

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/BK4532/news?page=27"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4532"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4532\",,,,,undefined,":{"symbol":"BK4532","market":"US","secType":"PLATE","nameCN":"Renaissance Technologies Holdings","latestPrice":1844.8641,"timestamp":1742327999999,"preClose":1870.2081,"halted":0,"volume":959537683,"delay":0,"changeRate":-0.013551,"change":-25.343994,"pbRate":8.425686,"amount":107553158297.9851,"amplitude":0.017761,"prevYearClose":2026.1482,"fiveDayClose":1837.4403,"twentyDayClose":2062.5247,"turnoverRate":0.007458,"marketCap":20574879421568,"floatMarketCap":19244819135728,"peRate":30.773927},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4532\",,,,,undefined,":{"symbol":"BK4532","high":1870.2552,"amplitude":0.017761,"preClose":1870.2081,"low":1837.0383,"pbRate":"8.425686","latestPrice":1844.8641,"volume":959537683,"delay":0,"open":1870.2552,"prevYearClose":2026.1482,"prevWeekClose":1867.1416,"prevMonthClose":1965.7411,"prevQuarterClose":2026.1482,"fiveDayClose":1837.4403,"twentyDayClose":2062.5247,"sixtyDayClose":2089.6423,"secType":"PLATE","market":"US","turnoverRate":0.007458,"peRate":30.773927,"marketCap":20574879421568,"floatMarketCap":19244819135728,"timestamp":1742327999999,"nameCN":"Renaissance Technologies Holdings"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4532\",,,,undefined,":{"bkCode":"BK4532","up":31,"down":63,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4532\",pageSize:16,pageCount:27,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2519833811","title":"These 20 stocks are likely to be losers no matter what the market does","url":"https://stock-news.laohu8.com/highlight/detail?id=2519833811","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519833811?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:45","pubTimestamp":1741866300,"startTime":"0","endTime":"0","summary":"Certain stocks are likely to lose money, even if the U.S. stock market stops declining and starts rising again.No one knows if the stock market decline that began on Feb. 19 will be the beginning of a major bear market, of course. But a recent study found that certain stocks are good bets to lose money, regardless of how the overall stock market performs. The study, entitled \"The Dynamics of Disagreement,\" was conducted by Kent Daniel of Columbia Business School, Alexander Klos of Germany's Kiel University and Simon Rottke of the University of Amsterdam. . On several occasions in recent years I've applied the study's methodology to stocks within the S&P 1500, constructing updated lists of Constrained Winners and Constrained Losers. The most recent list was published in early April 2024, and the stocks mentioned have performed as expected. The Constrained Winners list produced an average loss of 8.4% , while the Constrained Losers produced an average loss of 9.3%. Over the same period, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4177","BK4585","LU1861215975.USD","BK4547","HIMS","BK4535","BK4543","BK4533","LU2211815571.USD","CLF","SMCI","LU1861220033.SGD","BK4006","BK4196","BK4534","LUMN","LU2065731478.USD","BK4501","BK4588","LU0053671581.USD","BK4577","GME","BK4170","MRNA","TPL","BK4213","BK4089","BK4548","BK4139","BK4532","BK4568","BK4551","LU0149725797.USD","CELH","BK4554","BK4076"],"gpt_icon":1},{"id":"2519083340","title":"Tech Stocks Are Plummeting: 2 Artificial Intelligence (AI) Stocks to Buy Now and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2519083340","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519083340?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:45","pubTimestamp":1741866300,"startTime":"0","endTime":"0","summary":"Technology stocks are under pressure as investors look to book profits in an uncertain economic scenario.The massive long-term opportunity in artificial intelligence means that the recent sell-off opened a potential buying opportunity as well.Two AI leaders are on track to deliver healthy long-term growth, making them ideal candidates to buy on the dip.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/03/13/tech-stocks-are-plummeting-2-artificial-intelligen/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0080751232.USD","LU1852331112.SGD","SG9999014880.SGD","LU1551013425.SGD","LU0642271901.SGD","LU2065171402.SGD","BK4532","LU2417539215.USD","IE00BJLML261.HKD","LU2236285917.USD","LU2462157665.USD","LU1316542783.SGD","LU0323591593.USD","AIP","LU1084165304.USD","LU0203345920.USD","LU0316494557.USD","PLTR","LU0980610538.SGD","LU0267386448.USD","LU0107464264.USD","AI","LU2362541513.USD","LU0312595415.SGD","LU0094547139.USD","PC","IE00BHPRN162.USD","LU0957791311.USD","LU1303367103.USD","LU1868836914.USD","LU1043141123.HKD","LU0149725797.USD","LU1914381329.SGD","LU0466842654.USD","LU1935042991.SGD","SG9999015986.USD","LU2098885051.SGD","SG9999018865.SGD","IE0034235188.USD","LU0265550359.USD","LU0056508442.USD","IE00BK4W5L77.USD","LU2111349929.HKD","LU0048573561.USD","LU2756315318.SGD","BK4566","IE00BK4W5M84.HKD","LU0444971666.USD","BK4579"],"gpt_icon":1},{"id":"2519800508","title":"BUZZ-Citigroup starts coverage on Moderna, notes risky path to profitability","url":"https://stock-news.laohu8.com/highlight/detail?id=2519800508","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519800508?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:26","pubTimestamp":1741865215,"startTime":"0","endTime":"0","summary":"BUZZ-Citigroup starts coverage on Moderna, notes risky path to profitability** Citigroup starts coverage on vaccine maker Moderna MRNA.O with \"neutral/high risk\" rating and $40 PT, which represents a 14.3% upside to stock's last close** Company's transition away from its respiratory vaccine franchise will be challenging, with \"breakeven on a cash-cost basis is not internally projected to be until 2028\" - brokerage** Moderna's sales will remain primarily from its currently marketed respiratory vaccines, Spikevax and mRESVIA, with estimated sales of $1.4 bln and $1.1 bln in 2032, Citigroup says** \"Seasonality factors continue to have an impact\" on company's business, making its path to profitability \"risky\" due to fluctuations in demand and inventory management - brokerage** Says company's next-gen COVID and COVID+flu combo vaccines are expected to be approved in 2025, but are unlikely to be major growth drivers** Shares fell 63% in 2024  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nL4N3PW0UD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4501","BK4139","BK4534","BK4548","BK4585","BK4588","MRNA","BK4533","BK4532","BK4551"],"gpt_icon":1},{"id":"2519836673","title":"Investors in Vodafone Group (LON:VOD) have unfortunately lost 27% over the last three years","url":"https://stock-news.laohu8.com/highlight/detail?id=2519836673","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519836673?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:20","pubTimestamp":1741864846,"startTime":"0","endTime":"0","summary":"For many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk of stock picking is that you will likely buy under-performing companies. Unfortunately, that's been the case for longer term Vodafone Group Public Limited Company  shareholders, since the share price is down 44% in the last three years, falling well short of the market return of around 19%.Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns.It's good to see that Vodafone Group has rewarded shareholders with a total shareholder return of 14% in the last twelve months. And that does include the dividend. That certainly beats the loss of about 1.0% per year over the last half decade. We generally put more weight on the long term performance over the short term, but the recent improvement could hint at a  inflection","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/investors-vodafone-group-lon-vod-112046598.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4132","BK4532","BK4585","ISBC","VOD","BK4588","BK4211"],"gpt_icon":0},{"id":"2519800058","title":"Hello Group: Strategic Financial Maneuvers and Growth Prospects Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2519800058","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519800058?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:15","pubTimestamp":1741864544,"startTime":"0","endTime":"0","summary":"Hello Group (MOMO – Research Report), the Communication Services sector company, was revisited by a Wall Street analyst today. Analyst Fawne Jiang ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/hello-group-strategic-financial-maneuvers-and-growth-prospects-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/hello-group-strategic-financial-maneuvers-and-growth-prospects-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4009","BK4077","BK4502","BK4526","MOMO","BK4585","BK4588","BK4508","BK4532","BK4513","BK4531","WIMI"],"gpt_icon":0},{"id":"2519609880","title":"BRIEF-Rockwell Automation Showcases Emulate3D Factory Test For The First Time At NVIDIA GTC 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2519609880","media":"Reuters","labels":["productRelease","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519609880?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:15","pubTimestamp":1741864512,"startTime":"0","endTime":"0","summary":"BRIEF-Rockwell Automation Showcases Emulate3D Factory Test For The First Time At NVIDIA GTC 2025March 13 (Reuters) - NVIDIA Corp NVDA.O:ROCKWELL AUTOMATION SHOWCASES EMULATE3D FACTORY TEST FOR THE FIR","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nTUA5Z0MVK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVIW.SI","SG9999015358.SGD","NVDD","LU1861220033.SGD","LU1721428933.USD","LU0957808578.USD","NVD","LU0080751232.USD","LU1116320737.USD","LU1267930730.SGD","SGXZ23171101.USD","NVDS.UK","NVDU","BK4141","LU1551013425.SGD","LU0345768740.USD","LU0965509010.AUD","LU0323591593.USD","LU1894683264.USD","LU2237438978.USD","LU1267930573.SGD","BK4532","BK4605","HK0000306701.USD","SNVD.UK","LU2430703178.SGD","3NVD.UK","BK4543","LU2750360997.AUD","LU1674673691.USD","NVD3.UK","NVDA","LU0310800379.SGD","SG9999014559.SGD","2NVD.UK","NVDY","LU0466842654.USD","LU0238689110.USD","LU0964807845.USD","IE00BFSS8Q28.SGD","NVDS","LU0345769631.USD","NVD2.UK","LU2602419157.SGD","LU0957791311.USD","LU0061474705.USD","LU2023250330.USD","ROK"],"gpt_icon":0},{"id":"2519880399","title":"Press Release: Bristol Myers Squibb to Report Results for First Quarter 2025 on April 24, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2519880399","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519880399?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:11","pubTimestamp":1741864260,"startTime":"0","endTime":"0","summary":"Bristol Myers Squibb  will announce results for the first quarter of 2025 on Thursday, April 24, 2025. Company executives will review financial results with the investment community during a conference call beginning at 8:00 a.m. ET.Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, X, YouTube, Facebook and Instagram.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0237698245.USD","LU1868837300.USD","IE00BSNM7G36.USD","LU1670710661.SGD","LU0096364046.USD","LU1323610961.USD","LU1670711123.USD","LU1989771016.USD","IE00B2B36J28.USD","BK4581","LU0868494617.USD","LU1868836591.USD","LU1261432733.SGD","LU2133065610.SGD","LU2242652126.USD","LU0882574055.USD","LU1670710588.SGD","LU0225284248.USD","LU0306807586.USD","LU0985481810.HKD","LU1291159041.SGD","LU1093756168.USD","IE00BFXG1179.USD","IE00BJJMRZ35.SGD","LU0306806265.USD","LU1074936037.SGD","LU0114720955.EUR","MYE","LU1430594728.SGD","LU1868836914.USD","LU0225771236.USD","IE0009355771.USD","IE00BJT1NW94.SGD","IE0002141913.USD","LU0321505439.SGD","BK4585","BK4559","BK4532","LU1718418525.SGD","LU1571399168.USD","BK4534","LU0321505868.SGD","LU1868837136.USD","IE00BFTCPJ56.SGD","BK4007","LU1670711040.USD","LU1868836757.USD","BMY","LU0456855351.SGD","LU2125154935.USD"],"gpt_icon":0},{"id":"2519773887","title":"Logistics Report: China Chides Walmart; Target Revamps Grocery Supply Chain","url":"https://stock-news.laohu8.com/highlight/detail?id=2519773887","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519773887?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:03","pubTimestamp":1741863780,"startTime":"0","endTime":"0","summary":"China Chides Walmart; Target Revamps Grocery Supply Chain By Mark R. Long. Chinese authorities this week summoned and rebuked Walmart officials following complaints that the U.S. retail giant was leaning on some Chinese suppliers to cut prices to help it absorb the cost of U.S. tariffs.The WSJ's Hannah Miao and Raffaele Huang write that President Trump's decision to add a 20% tariff on Chinese imports on top of previous duties puts retailers like Walmart in a jam . Raising prices to recoup higher costs risks angering Trump and consumers, but getting suppliers to eat the higher costs isn't easy, either.China is under pressure, too, as the tariffs inflict pain on the country's export-dependent economy, which already is wrestling with overproduction and weak domestic demand. Some American businesses have been cutting their dependence on China as relations have deteriorated.Target used to rely on grocery wholesalers. The company said switching to its own food-distribution centers has given","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1280957306.USD","LU2505996681.GBP","BK4585","LU2125154778.USD","LU2471134796.USD","LU0211328371.USD","NEX.SI","LU1366192091.USD","LU0256863811.USD","LU2430703095.HKD","LU0211327993.USD","BK4533","LU2750360997.AUD","LU2471134523.USD","IE000M9KFDE8.USD","LU0175139822.USD","IE0034235188.USD","LU1267930490.SGD","LU2592432038.USD","LU1066051811.HKD","LU2461242641.AUD","WMT","BK6039","BK4504","BK4534","LU1035773651.USD","BK4596","BK4581","LU2430703251.USD","LU0289960550.SGD","LU0417517546.SGD","LU1066053197.SGD","LU0265550946.USD","BK4588","LU2361044949.HKD","LU2361045086.USD","LU2125154935.USD","LU1116320737.USD","LU1064131342.USD","LU0640476718.USD","LU2471134952.CNY","LU1988902786.USD","LU2360032135.SGD","BK4597","BK4532","LU1430594728.SGD","LU1814569148.SGD","LU2471134879.HKD","BBC","LU1069347547.HKD"],"gpt_icon":1},{"id":"2519887436","title":"BRIEF-Bristol Myers Squibb To Report Results For First Quarter 2025 On April 24, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2519887436","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519887436?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:01","pubTimestamp":1741863703,"startTime":"0","endTime":"0","summary":"BRIEF-Bristol Myers Squibb To Report Results For First Quarter 2025 On April 24, 2025March 13 (Reuters) - Bristol-Myers Squibb Co BMY.N:BRISTOL MYERS SQUIBB TO REPORT RESULTS FOR FIRST QUARTER 2025 ON","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nTUA7VZDRW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0061475181.USD","LU1093756325.SGD","LU1323610961.USD","LU0306806265.USD","LU2360032135.SGD","IE0002141913.USD","LU1093756168.USD","IE00BFXG1179.USD","LU1868837300.USD","IE00BFTCPJ56.SGD","LU0882574055.USD","LU0321505439.SGD","BK4585","LU1291159041.SGD","LU2125154778.USD","LU0114720955.EUR","LU1585245621.USD","LU0985481810.HKD","IE00BSNM7G36.USD","BK4559","LU0306807586.USD","LU1868836591.USD","IE00BJJMRZ35.SGD","LU2125154935.USD","LU2242646821.SGD","LU0237698245.USD","LU1571399168.USD","BMY","LU0096364046.USD","LU0225284248.USD","BK4581","BK4534","LU1670711123.USD","LU1868836757.USD","BK4007","LU1718418525.SGD","LU1989771016.USD","LU1261432733.SGD","LU1074936037.SGD","LU2133065610.SGD","IE00B2B36J28.USD","LU2242652126.USD","IE00BJT1NW94.SGD","IE0009355771.USD","LU0868494617.USD","LU1430594728.SGD","LU0456855351.SGD","LU0225771236.USD","LU1670710588.SGD","BK4532"],"gpt_icon":0},{"id":"2519617835","title":"EXCLUSIVE: Vivani Medical Announces First Implant In Early-Stage Human Study Of GLP-1 Implant For Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2519617835","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519617835?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:00","pubTimestamp":1741863637,"startTime":"0","endTime":"0","summary":"On Thursday, Vivani Medical, Inc.  announced the administration of its first GLP-1  implant in the LIBERATE-1 trial in Australia.Vivani's lead program, NPM-115, utilizes a miniature, six-month, subdermal, GLP-1  implant under development for chronic weight management in obese or overweight individuals.Also Read: EXCLUSIVE: Vivani Medical To Spin Off Cortigent Neurostimulation Business To Create Better Focus On Individual Entities And Shareholder Value. The company also announced full enrollment in the LIBERATE-1 study, which was achieved four weeks after the first subject enrolled, and reaffirmed that top-line results should be available in mid-2025.In December, Vivani Medical initiated screening and enrollment at two centers in Australia for the first-in-human LIBERATE-1 trial.The LIBERATE-1 study is exploring the full pharmacokinetic profile of NPM-115, which has demonstrated consistently smooth and minimally fluctuating drug release in vitro and in animal models.LIBERATE-1 is a Phas","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exclusive-vivani-medical-announces-first-110037673.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","LU0320765992.SGD","VANI","LU2236285917.USD","LU0889565916.HKD","LU2456880835.USD","BK4144","LU1093756325.SGD","BK4588","GLP","BK4568","BK4082","BK4590","LU2462157665.USD","LU1829250122.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4532","LU1093756168.USD","AZN","BK4585","SSI","LU0154236417.USD","LU2417539215.USD","LU0109394709.USD","BK4599"],"gpt_icon":1},{"id":"2519683532","title":"Linde plc's (NASDAQ:LIN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2519683532","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519683532?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:00","pubTimestamp":1741863621,"startTime":"0","endTime":"0","summary":"With its stock down 3.6% over the past week, it is easy to disregard Linde . However, stock prices are usually driven by a company’s financial performance over the long term, which in this case looks quite promising. Specifically, we decided to study Linde's  ROE in this article.ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In other words, it is a profitability ratio which measures the rate of return on the capital provided by the company's shareholders.Return on equity can be calculated by using the formula:. Return on Equity = Net Profit  ÷ Shareholders' Equity. A Side By Side comparison of Linde's Earnings Growth And 17% ROE. The three-year median payout ratio for Linde is 42%, which is moderately low. The company is retaining the remaining 58%. By the looks of it, the dividend is well covered and Linde is reinvesting its profits efficiently as evidenced by its exceptional gro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/linde-plcs-nasdaq-lin-fundamentals-110021354.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2087625088.SGD","LU0969580488.USD","LU0724618433.USD","LIN","MNQmain","LU0957791311.USD","LU0353189763.USD","USJW.SI","NDAQ","LU1988902786.USD","LU1620156213.USD","QID","QLD","LU1978683503.SGD","BK4534","LU0769137737.USD","LU2463526074.USD","LU2298322129.HKD","TQQQ","BK4532","LU0171280430.USD","LU2264538146.SGD","LU2095319765.USD","USAW.SI","PSQ","IE00BKPKM429.USD",".IXIC","LU1791806182.HKD","LU0171277485.USD","LU0096362180.USD","TSYW.SI","LU1355424745.HKD","IE00BGHQF748.EUR","BK4566","SQQQ","LU1104425308.USD","LU0061474960.USD","LU0526926950.USD","LU0234572021.USD","LU1196525536.USD","NVIW.SI","LU2413665964.HKD","LU2210149790.SGD","BK4588","LU1721427968.SGD","LU2355687059.USD","NQmain","LU2265009873.SGD","LU1989772840.SGD"],"gpt_icon":1},{"id":"2519034880","title":"Snowflake Insiders Added US$15.0m Of Stock To Their Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2519034880","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519034880?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:00","pubTimestamp":1741863608,"startTime":"0","endTime":"0","summary":"Multiple insiders secured a larger position in Snowflake Inc.  shares over the last 12 months. This is reassuring as this suggests that insiders have increased optimism about the company's prospects.While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.An insider hasn't bought Snowflake stock in the last three months, but there was some selling. But we take heart from prior transactions. And insider ownership remains quite considerable. So we're not too bothered by recent selling. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. To assist with","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/snowflake-insiders-added-us-15-110008404.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4503","LU1803068979.SGD","BK4607","BK4581","BK4505","LU0109392836.USD","LU1951198990.SGD","LU0889565833.HKD","LU1923623000.USD","BK4585","BK4548","BK4116","BK4535","BK4613","LU1951200564.SGD","BK4554","BK4588","BK4532","BK4551","SNOW","BK4559"],"gpt_icon":1},{"id":"2519887682","title":"Press Release: AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2519887682","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519887682?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:00","pubTimestamp":1741863600,"startTime":"0","endTime":"0","summary":"-- Landmark exclusive option and license deal with Takeda for ACI-24.060. with $100 million upfront and additional potential milestones of up to. about $2.1 billion plus royalties on sales upon commercialization. -- ACI-24.060 ABATE Phase 1b/2 trial showed encouraging interim safety and. tolerability data in Down syndrome  cohort; further interim results. in Alzheimer's disease  and DS expected in 2025. -- Enrollment progress in JNJ-2056  ReTain Phase 2b trial in. preclinical AD patients triggered second milestone payment of CHF 24.6. -- ACI-7104.056 VacSYn Phase 2 trial demonstrated positive interim safety. and immunogenicity results in Parkinson's disease ; further interim. \"The ability to innovate is key to our future success. Driven by our two drug discovery platforms, in 2024, we advanced multiple early-stage asse","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE00BSNM7G36.USD","LU0320765646.SGD","SG9999002224.SGD","LU0640476718.USD","LU1244550494.USD","IE000M9KFDE8.USD","LU0792757196.USD","AAIC","LU2089984988.USD","BK4604","03160","TM","LU0203345920.USD","JNJ","LU1032466523.USD","LU1059921491.USD","BK4532","LU1778281490.HKD","CBD","R","IE00BDGV0183.EUR","LU1162221912.USD","IE0009355771.USD","IE00B4R5TH58.HKD","PSP","AC","BK4581","LU0114720955.EUR","LU1169589451.USD","LU1506573853.SGD","LU0234572021.USD","BK4592","LU0098860793.USD","LU1221951129.SGD","PET","IE00B2B36J28.USD","IE00B42XCP33.USD","ACI","LU0345769128.USD","LU1244550577.SGD","LU2505996509.AUD","LU2430703095.HKD","BK4555","LU0912757837.SGD","ACIU","ARIA","IE00BVYPNV92.GBP","PD","LU0234570918.USD"],"gpt_icon":0},{"id":"2519893887","title":"Bristol Myers Squibb to Report Results for First Quarter 2025 on April 24, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2519893887","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519893887?lang=en_us&edition=fundamental","pubTime":"2025-03-13 18:59","pubTimestamp":1741863540,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nTUA7VZDRW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BJT1NW94.SGD","BK4534","LU1868837300.USD","LU2242646821.SGD","LU0321505868.SGD","LU1032466523.USD","LU0096364046.USD","BK4581","LU1261432733.SGD","LU0225284248.USD","IE00BJJMRZ35.SGD","LU1291159041.SGD","LU1093756168.USD","LU0061475181.USD","LU1670711040.USD","LU2125154778.USD","LU0306807586.USD","LU1868837136.USD","LU1868836914.USD","IE00BFXG1179.USD","IE00BFTCPJ56.SGD","LU1074936037.SGD","LU1093756325.SGD","LU0237698245.USD","LU2360032135.SGD","BMY","IE00BSNM7G36.USD","LU0985481810.HKD","LU1670711123.USD","LU1670710661.SGD","BK4588","LU1323610961.USD","LU0225771236.USD","BK4532","BK4007","IE00B2B36J28.USD","LU0306806265.USD","IE0002141913.USD","LU0321505439.SGD","LU1585245621.USD","IE0009355771.USD","LU0114720955.EUR","LU0456855351.SGD","BK4559","LU0868494617.USD","LU0882574055.USD","LU1571399168.USD","LU1670710588.SGD","BK4585","LU2242652126.USD"],"gpt_icon":0},{"id":"2519875098","title":"Trump's Chips War Has Left Intel's New CEO With a Near-Impossible Task. Here's Why and 5 Other Things to Know Today. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2519875098","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519875098?lang=en_us&edition=fundamental","pubTime":"2025-03-13 18:58","pubTimestamp":1741863480,"startTime":"0","endTime":"0","summary":"It's possibly the hardest job in corporate America and Lip-Bu Tan is likely the best appointment. But it might be too much to ask Intel's new CEO to restore an icon of U.S. high-tech manufacturing to its former glory.Reviving Intel's chip-fabricating operations is the most difficult part of Tan's job, and one that chimes with the Trump administration's bid to revive American manufacturing. Secure supply chains are key to that goal and ensuring them for semiconductors is arguably the most important pillar -- beyond even steel or cars.However, President Donald Trump might make Tan's job even harder as he campaigns for a stop to the Chips Act -- which is set to grant up to $8.5 billion in direct funding to Intel as a big incentive to set up new factories across the U.S. Instead, the president hopes to achieve similar goals via the threat of tariffs, which he claims encouraged Taiwan Semiconductor Manufacturing -- the company that replaced Intel as the world's leading maker of advanced chi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505439.SGD","LU0471298777.SGD","BK4532","LU0082616367.USD","LU1917777945.USD","IE00B2B36J28.USD","LU2237438978.USD","LU2458330243.SGD","INTC","BK4007","LU0345774631.USD","LU2491050071.SGD","US7Y.BOND","BK4581","RHHBY","LU2095319765.USD","LU0079474960.USD","LU1548497426.USD","BK4567","US5Y.BOND","LU0256863811.USD","LU1712237335.SGD","BK4512","03165","BK4566","LU2125154778.USD","LU0965509101.SGD","US30Y.BOND","BK4592","US6M.BOND","LU0792757196.USD","LU2089984988.USD","US12M.BOND","LU2361044949.HKD","US3Y.BOND","LU0719512351.SGD","LU0234572021.USD","LU0640476718.USD","SG9999014898.SGD","LU0109392836.USD","SG9999001176.USD","US2Y.BOND","LU2361044865.SGD","BK4612","US10Y.BOND","LU1035775433.USD"],"gpt_icon":1},{"id":"2519688768","title":"ForexIGO Bridges Gold and GBP/USD Trading in a Single AI Solution","url":"https://stock-news.laohu8.com/highlight/detail?id=2519688768","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519688768?lang=en_us&edition=fundamental","pubTime":"2025-03-13 18:49","pubTimestamp":1741862963,"startTime":"0","endTime":"0","summary":"ForexIGO, an AI-powered Expert Advisor , introduces a dual-market strategy designed to optimize both gold  and GBP/USD trading within the MetaTrader 4  platform. Built to enhance diversification and efficiency, this EA allows traders to capitalize on opportunities in two markets while maintaining a balanced risk approach.Multi-market trading has traditionally required managing separate strategies, each tailored to different asset classes. Gold and GBP/USD behave differently, one driven by macroeconomic forces and risk sentiment, the other by monetary policy and economic indicators. ForexIGO unites these markets within a single framework, enabling traders to leverage AI-driven insights for smarter execution.Managing multiple markets manually can be overwhelming, requiring constant monitoring and adjustments to account for shifting correlations, volatility spikes, and trend reversals. ForexIGO eliminates that burden, autonomously tracking gold and GBP/USD price action, and adjusting stra","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/67d2b834f2aa06741674d63a/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["LU0823417653.USD","BK4532","LU2247934214.USD","BK4085","BK4585","LU1430594728.SGD","USD","LU0950375773.USD","BK4533","EA","LU2506951875.HKD","LU0006061336.USD","LU2506952170.USD","LU1585245621.USD","LU2506951958.HKD","BK4577","LU0823417737.USD","LU2506952097.USD","BK4588"],"gpt_icon":0}],"pageSize":16,"totalPage":89,"pageCount":27,"totalSize":1420}]}}